(Q41506945)

1 October 2017

title

LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway (English)

1 reference

1 October 2017

Qin Luo

1

1 reference

1 October 2017

Cun Wang

2

1 reference

1 October 2017

Guangzhi Jin

3

1 reference

1 October 2017

Dishui Gu

4

1 reference

1 October 2017

Ning Wang

5

1 reference

1 October 2017

Jin Song

6

1 reference

1 October 2017

Haojie Jin

7

1 reference

1 October 2017

Fangyuan Hu

8

1 reference

1 October 2017

Yurong Zhang

9

1 reference

1 October 2017

Tianxiang Ge

10

1 reference

1 October 2017

Xisong Huo

11

1 reference

1 October 2017

Wei Chu

12

1 reference

1 October 2017

Huiqun Shu

13

1 reference

1 October 2017

Jingyuan Fang

14

1 reference

1 October 2017

Ming Yao

15

1 reference

1 October 2017

Jianren Gu

16

1 reference

1 October 2017

Wenming Cong

17

1 reference

1 October 2017

Wenxin Qin

18

1 reference

1 October 2017

language of work or name

English

0 references

publication date

27 July 2015

1 reference

1 October 2017

1 reference

1 October 2017

volume

36

1 reference

1 October 2017

issue

10

1 reference

1 October 2017

page(s)

1201-1212

1 reference

Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Hepatocellular carcinoma: clinical frontiers and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

The fundamental role of mechanical properties in the progression of cancer disease and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Oct-3/4 promotes migration and invasion of glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

Janus kinases: components of multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV108

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGV108

1 reference

1 October 2017

1 reference